Outcome in advanced non-small cell lung cancer patients with successful rechallenge after recovery from epidermal growth factor receptor tyrosine kinase inhibitor-induced interstitial lung disease
Crossref DOI link: https://doi.org/10.1007/s00280-017-3261-5
Published Online: 2017-03-03
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kashiwabara, Kosuke
Semba, Hiroshi
Fujii, Shinji
Tsumura, Shinsuke
License valid from 2017-03-03